Tiblan, Al-nashier A.
HRN: 25-77-62 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2024
CEFUROXIME 750MG (VIAL)
08/24/2024
08/31/2024
IV
450 Mg
Q 8 Hours
PCAP-C
Waiting Final Action